<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel rdf:about="http://www.jmor.jp/">
    <title>日本卵子学会 Online Journal</title>
    <link>http://www.jmor.jp/</link>
    <description><![CDATA[日本卵子学会オンラインジャーナルサイト。論文検索と全文PDFのダウンロードができます。]]></description>
    <prism:publicationName>日本卵子学会雑誌</prism:publicationName>
    <items>
      <rdf:Seq/>
    </items>
  </channel>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6357&amp;amp;-action=browse">
    <title></title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6357&amp;-action=browse</link>
    <dc:title><![CDATA[]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[]]></dc:creator>
    <description><![CDATA[]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>1</prism:startingPage>
    <prism:section></prism:section>
  </item>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6358&amp;amp;-action=browse">
    <title>Vitrification/warming protocols and practical techniques for human cleavage and blastocyst stage embryos</title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6358&amp;-action=browse</link>
    <dc:title><![CDATA[Vitrification/warming protocols and practical techniques for human cleavage and blastocyst stage embryos]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[Ryosuke Suzuki*, Kana Tsukamoto, Akiyo Kikumoto, Toshihiko Kyoya, Kentaro Fujita, Shun Yamamoto, Atsushi Yamamoto, Suguru Saito and Junichi Kobayashi]]></dc:creator>
    <description><![CDATA[Embryo cryopreservation has become an essential technique in assisted reproductive technology. Advances in freezing and thawing technologies have provided many clinical benefits, including reduced risks of multiple pregnancies and ovarian hyperstimulation syndrome. In frozen-thawed embryo transfer, clinical outcomes are expected to improve through synchronization of the embryo and endometrium. By increasing the cumulative clinical pregnancy rate per oocyte retrieval, this approach is also considered to contribute to a reduction in the physical, emotional, and financial burdens of patients. As frozen-thawed embryo transfer has become widely used, several manufacturers now provide various vitrification/warming solutions and devices, which have characteristics and protocols that vary among products. In recent years, methods that shorten the warming process have also been reported. Embryologists need to evaluate these methods and choose the most appropriate one for their facility. In this article, we describe a protocol using the Ready to Vitri/Warm Kit, a vitrification/warming kit, and introduce practical techniques used at our clinic.]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>3</prism:startingPage>
    <prism:section></prism:section>
  </item>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6359&amp;amp;-action=browse">
    <title>Mastering vitrification in the lab: From the fundamentals to quality management</title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6359&amp;-action=browse</link>
    <dc:title><![CDATA[Mastering vitrification in the lab: From the fundamentals to quality management]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[Tetsuya Miki, Kenji Ezoe, Nanoha Fujiwara and Keiichi Kato*]]></dc:creator>
    <description><![CDATA[With the advancement of cryopreservation techniques, embryo vitrification has become an essential component of assisted reproductive technology. In Japan, a large proportion of neonates born through <I>in vitro</I> fertilisation are derived from frozen embryos. In addition, the introduction of insurance coverage in 2022 has reduced the financial barriers to infertility treatment, thereby increasing the number of patients and the demand for frozen embryo transfer. On the other hand, the number of embryo transfers covered by insurance is limited. Therefore, to maximise pregnancy outcome per embryo transfer, it is crucial to produce and select high-quality embryos, as well as to apply advanced cryopreservation techniques. Furthermore, maintaining a consistent standard of cryopreservation techniques and ensuring stable outcomes requires a proper quality management system. In light of these circumstances, this article presents the principles and protocols of cryopreservation, highlights the significance of implementing quality management to improve and stabilise clinical outcomes, and introduces specific initiatives undertaken at our clinic.]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>13</prism:startingPage>
    <prism:section></prism:section>
  </item>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6360&amp;amp;-action=browse">
    <title>Vitrification and warming of human embryos: from conventional methods to shortened protocols</title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6360&amp;-action=browse</link>
    <dc:title><![CDATA[Vitrification and warming of human embryos: from conventional methods to shortened protocols]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[Masashi Shioya]]></dc:creator>
    <description><![CDATA[The transition of human oocyte and embryo cryopreservation techniques from slow-freezing to vitrification has led to survival rates approaching 100%, resulting in a global increase in the proportion of freeze-all cycles and vitrified-warmed embryo transfers. The vitrification and warming protocols currently in use have been implemented in ART centers worldwide for nearly two decades and can be considered an established technique. However, with the recent advancement and diversification of ART, there is a growing demand to improve the efficiency of the IVF laboratory workflow. In particular, the simplification of vitrification and warming procedures, which has been reported in the last few years, is gaining attention as a technique to enhance laboratory efficiency while maintaining embryo survivability, as well as developmental and implantation potential. This review first describes the standard vitrification and warming procedures, then, including data from our center, focuses on the simplification of protocols which have been reported in recent years, especially the shortened warming protocol, and report on their efficacy.]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>23</prism:startingPage>
    <prism:section></prism:section>
  </item>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6361&amp;amp;-action=browse">
    <title>Chemicals for improving the viability of vitrified-warmed bovine oocytes</title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6361&amp;-action=browse</link>
    <dc:title><![CDATA[Chemicals for improving the viability of vitrified-warmed bovine oocytes]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[Shinichi Hochi]]></dc:creator>
    <description><![CDATA[Unfertilized bovine oocytes are rich in cryo-sensitive cytoplasmic lipid droplets and less permeable to water and CPA due to their spherical shape, which has the smallest surface to volume ratio, making cryopreservation difficult by the conventional freeze-thawing procedure. Over the last few decades, applying innovative vitrification-warming procedures, characterized by ultra-rapid cooling in a very limited amount of cryoprotective solution (MVC vitrification), has improved oocyte cryopreservation, enabling high quality blastocyst production after IVF/ICSI of warmed oocytes. However, the developmental competence of vitrified-warmed bovine oocytes still needs to be improved. In this article, the efficiencies of bovine blastocyst production from warmed mature M-II-stage oocytes are listed as a function of cryodevice types in the MVC vitrification. Furthermore, low MW chemicals (L-carnitine, resveratrol, α-tocopherol, ROCK inhibitor Y-27632, etc.), which have been reported to improve warmed oocyte viability in some domestic species, are highlighted for their structure, timing of oocyte treatment, and extent of viability improvement.]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>33</prism:startingPage>
    <prism:section></prism:section>
  </item>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6362&amp;amp;-action=browse">
    <title>The relationship between chromosomal abnormalities in embryos and developmental kinetics and iDAScore version 2.0</title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6362&amp;-action=browse</link>
    <dc:title><![CDATA[The relationship between chromosomal abnormalities in embryos and developmental kinetics and iDAScore version 2.0]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[Taiyo Yamamoto, Katsuya Mine, Takashi Katsuyama and Hisataka Iwata*]]></dc:creator>
    <description><![CDATA[Preimplantation genetic testing for aneuploidy (PGT-A) has been widely used to increase the success rate of embryo transfer; however, the relationship between PGT-A results and embryonic developmental kinetics and evaluation scores remains unclear. In this study, we compared patient age, developmental kinetics determined by a time-lapse incubator, and the embryonic evaluation score assessed by iDAScore Ver.2.0 with the results of PGT-A. Data from 193 blastocysts from 99 couples who underwent PGT-A at our clinic between January 2020 and May 2024 were used in a retrospective analysis. Compared to aneuploid embryos, embryos assessed as normal by PGT-A were on average derived from younger females, irrespective of the fertilization method (conventional <I>in vitro</I> fertilization or intracytoplasmic sperm injection). Aneuploidy delayed embryonic development and decreased the iDAScore, irrespective of the fertilization method, and the aneuploidy-induced delay in developmental kinetics of embryos derived from aged patients (≧38 years) was more apparent than that of embryos derived from younger patients (<38 years). Aneuploidy patterns (chromosomal increases or decreases) affected the iDAScore Ver.2.0. Overall, a low iDAScore reflected chromosomal abnormalities, but this was not the case for all types of abnormalities.]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>39</prism:startingPage>
    <prism:section></prism:section>
  </item>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6363&amp;amp;-action=browse">
    <title>In vitro development of bovine embryos using a two-step culture method</title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6363&amp;-action=browse</link>
    <dc:title><![CDATA[In vitro development of bovine embryos using a two-step culture method]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[Shunpei Oguma, Ryotaro Miura, Hiroshi Tajimi, Aya Iwaki, Kana Hasegawa, Erina Sasaki, Konosuke Okada, Kenji Furui and Hitoshi Ushijima*]]></dc:creator>
    <description><![CDATA[We examined a two-step culture method for bovine <I>in vitro</I> embryo production (IVEP). Modified synthetic oviduct fluid without glucose (mSOF) was used for early-cleavage-stage embryos, followed by 5% fetal calf serum (FCS) supplemented with SOF for morula-stage embryos. When SOF+FCS was used for the latter half of culture, the blastocyst development rate was significantly higher (<I>P</I> < 0.05) than in culture in mSOF for the full 7 days after IVF. When TCM199 supplemented with 5.54 mM glucose, FCS, and 0.1 mM <I>β</I>-mercaptoethanol was used for the latter half of the culture there was no significant difference in the blastocyst rate from that of SOF+FCS, but at 6 and 9 days after IVEP, the cell numbers of embryos were significantly greater in the TCM199 supplemented medium. These results show that glucose in the medium is important for embryonic development and that switching to an energy-rich medium at the morula stage is beneficial for the production of high-quality embryos.]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>47</prism:startingPage>
    <prism:section>Brief Note</prism:section>
  </item>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6364&amp;amp;-action=browse">
    <title>Effects of supplementation of growth factors to in vitro maturation medium on early embryonic development and gene expression in bovine in vitro fertilized embryos</title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6364&amp;-action=browse</link>
    <dc:title><![CDATA[Effects of supplementation of growth factors to in vitro maturation medium on early embryonic development and gene expression in bovine in vitro fertilized embryos]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[Hinano Kozuka, Shunki Ono, Kota Okubo, Takashi Fujii and Ken Sawai*]]></dc:creator>
    <description><![CDATA[Bovine <i>in vitro</i> fertilization (IVF) technology is valuable for the efficient production of quality calves. However, bovine IVF embryos have problems such as low embryonic development and conception rates and frequent occurrence of large-offspring syndrome due to abnormal gene expression. The addition of FLI (FGF2, LIF, and IGF1) to <i>in vitro</i> maturation (IVM) medium improves oocyte maturation. Therefore, this study examined the effects of FLI addition to IVM medium on the maturation of oocytes, and preimplantation development, and the gene expression status of bovine embryos after IVF. There was no significant difference in the nuclear maturation rates of oocytes matured in IVM medium with or without FLI supplementation. The blastocyst developmental rate and mRNA expression levels (<i>FGF4</i>, <i>IGFBP-2</i>, <i>OCT-4</i>, <i>CDX2</i>, and <i>AQP3</i>) showed no differences between maturation in IVM medium with or without FLI supplementation. In conclusion, our results show that different IVM media and the addition of FLI did not affect the nuclear maturation of bovine oocytes, preimplantation development or gene expression status of bovine IVF embryos.]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>53</prism:startingPage>
    <prism:section>Original</prism:section>
  </item>
  <item rdf:about="http://www.jmor.jp/abstract.php?-DB=jmor&amp;amp;-recid=6365&amp;amp;-action=browse">
    <title>Impact of low-level laser irradiation on female mouse fertility</title>
    <link>http://www.jmor.jp/abstract.php?-DB=jmor&amp;-recid=6365&amp;-action=browse</link>
    <dc:title><![CDATA[Impact of low-level laser irradiation on female mouse fertility]]></dc:title>
    <dc:publisher>日本卵子学会</dc:publisher>
    <dc:date>2026-04-01T00:00:00</dc:date>
    <dc:creator><![CDATA[Shoji Kokeguchi, Yuta Tsuji, Yui Asada, Masayoshi Yamaguchi, Masahide Shiotani* and Yoko Kato*]]></dc:creator>
    <description><![CDATA[In this study, we investigated the effects of low-level laser therapy (LLLT) on the reproductive traits of ICR female mice. First, we examined the relationship between age and reproductive performance, and observed that in retired breeders, both the mating rate and total ovulation number decreased. In contrast, the developmental competence of collected fertilized embryos and parthenogenetic embryos was not impaired. Next, we externally irradiated one ovarian region of the same individual mice with LLLT seven times and evaluated their reproductive traits. In retired females, an improvement in oocyte number was observed on the irradiated side compared with the non-irradiated side. We then compared the reproductive traits of LLLT-irradiated and non-irradiated mice. In retired females, the total number of ovulated oocytes per mouse slightly increased following LLLT, but the difference was not significant. When LLLT was applied regularly from 8 to 36 weeks of age, it led to improved mating rates, fertilization rates, and blastocyst formation rates of both fertilized and parthenogenetic embryos. These findings suggest that LLLT may exert beneficial effects on female reproductive function when applied continuously over an extended period.]]></description>
    <prism:volume>43</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>61</prism:startingPage>
    <prism:section>Original</prism:section>
  </item>
</rdf:RDF>
